News
A new antibody shot that protects babies against RSV infection could be struggling to gain traction, Philadelphia researchers ...
Cancer patients who receive COVID boosters are far less likely to be hospitalized, but vaccination rates remain alarmingly low, researchers report.
20h
Daily Democrat on MSNWhat cats may teach us about long COVIDFeline infectious peritonitis, or FIP, is a serious and historically fatal disease in cats caused by a coronavirus. It behaves in many ways like severe coronavirus infections in humans, causing ...
Real-time urine drug test data accurately estimate overdose deaths, which could help primary care providers evaluate their community’s health and the effectiveness of interventions, according to an ...
Gain-of-function experiments are ingrained in the scientific process. In many instances, the benefits that stem from gain-of-function experiments are not immediately clear. Only decades later does the ...
The US Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) have launched investigations ...
PepsiCo offers strong dividend growth potential with a stable credit rating and a 14% discount on fair value. Click here to ...
Tiny fat bubbles carrying gene therapy have successfully repaired DNA in the lungs and liver of animals with alpha-1 ...
22h
New Vision on MSNSelf-medication among Ugandans alarms health expertsPotential risks of self-medication include incorrectly self-diagnosing and taking the wrong medication, which leads to several complications, hence making it harder to treat illnesses.
Despite offering significant protection against severe COVID-19, patients with cancer, a high-risk group, showed low uptake of booster vaccinations.
19h
News-Medical.Net on MSNCOVID-19 boosters reduce hospitalization risk for cancer patientsVaccine boosters help keep cancer patients from being hospitalized or admitted to intensive care units due to COVID-19, according to a new study led by Cedars-Sinai investigators.
A new study by a Tulane University researcher casts doubt on a widely used shortcut in rectal cancer drug trials, raising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results